LATEST NEWS & PUBLICATIONS
CMS 2026 ASP Reporting Update: Reasonable Assumptions Form Due April 30
CMS 2026 ASP Reporting Update: Reasonable Assumptions Form Due April 30 Under the 2026 CMS Final Rule, pharmaceutical manufacturers face a new compliance requirement: beginning with Q1 2026 ASP reporting, manufacturers must submit a Reasonable Assumptions Form...
PBM Reform Is Here: What the 2026 Appropriations Act Changes
Congress Just Drew a Line on PBM Compensation Recently, President Trump signed the Consolidated Appropriations Act of 2026, avoiding a government shutdown and setting federal funding for the year. Included inside the bill is a major policy change that will reshape how...
Nevada Essential Drug List Reporting Requirements for Pharmaceutical Manufacturers
Nevada Essential Drug List Reporting Requirements for Pharmaceutical Manufacturers Nevada’s drug price transparency law includes annual reporting obligations for pharmaceutical manufacturers whose products appear on the Nevada Essential Drug List. Inclusion on the...
OUR DIFFERENCE
Access
- Direct access to your analyst and company leadership
- Available 24/7 to support your needs
Accuracy
- Apply discipline to fully compliant SOPs
- All deliverables subject to strict layers of reviews and audits
Dependability
- Consistent ownership & business partners
- Vested in your long-term success
Transparency
- Clients own all data
- Full access to all scrubbed data, computations and processes
Problems Solved — Opportunities Leveraged.
Find out how we can support your critical analytic, processing and financial functions.